These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21460772)

  • 1. Drug-eluting stents above the knee.
    Minar E
    J Cardiovasc Surg (Torino); 2011 Apr; 52(2):225-9. PubMed ID: 21460772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolving modalities for femoropopliteal interventions.
    Ansel GM; Lumsden AB
    J Endovasc Ther; 2009 Apr; 16(2 Suppl 2):II82-97. PubMed ID: 19624076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does endovascular treatment of infra-inguinal arterial disease with drug-eluting stents offer better results than angioplasty with or without bare metal stents?
    Antoniou GA; Georgakarakos EI; Antoniou SA; Georgiadis GS
    Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):282-5. PubMed ID: 24729201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug eluting stents and modern stent technologies for in-stent restenosis.
    Werner M
    J Cardiovasc Surg (Torino); 2017 Aug; 58(4):497-500. PubMed ID: 28382805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-coated balloons in the lower limb.
    Zeller T; Schmitmeier S; Tepe G; Rastan A
    J Cardiovasc Surg (Torino); 2011 Apr; 52(2):235-43. PubMed ID: 21460774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-eluting stents below the knee.
    Bosiers M; Deloose K; Callaert J; Keirse K; Verbist J; Peeters P
    J Cardiovasc Surg (Torino); 2011 Apr; 52(2):231-4. PubMed ID: 21460773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-year analysis of the Japanese cohort from the Zilver PTX randomized controlled trial supports the validity of multinational clinical trials.
    Ohki T; Yokoi H; Kichikawa K; Kimura T; Snyder SA; Ragheb AO; O'Leary EE; Jaff MR; Ansel GM; Dake MD
    J Endovasc Ther; 2014 Oct; 21(5):644-53. PubMed ID: 25290792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions.
    Zeller T; Rastan A; Macharzina R; Tepe G; Kaspar M; Chavarria J; Beschorner U; Schwarzwälder U; Schwarz T; Noory E
    J Endovasc Ther; 2014 Jun; 21(3):359-68. PubMed ID: 24915582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for the use of drug eluting stents in below-the-knee lesions.
    Trombert D; Caradu C; Brizzi V; Bérard X; Midy D; Ducasse E
    J Cardiovasc Surg (Torino); 2015 Feb; 56(1):67-71. PubMed ID: 25428562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential role of DES in peripheral in-stent restenosis.
    Zeller T; Macharzina R; Tepe G
    J Cardiovasc Surg (Torino); 2010 Aug; 51(4):561-5. PubMed ID: 20671640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which is currently the best strategy for treatment of SFA in-stent restenosis?
    Elens M; Verbist J; Keirse K; Van Den Eynde W; Peeters P
    J Cardiovasc Surg (Torino); 2014 Aug; 55(4):477-81. PubMed ID: 24941234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sense and nonsense of bare metal stents below the knee.
    Caradu C; Brizzi V; Auque H; Midy D; Ducasse E
    J Cardiovasc Surg (Torino); 2016 Oct; 57(5):653-66. PubMed ID: 27177357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel Drug-Eluting Stents in Peripheral Arterial Disease: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2015; 15(20):1-62. PubMed ID: 26719778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel-Coated Zilver PTX Drug-Eluting Stent Treatment Does Not Result in Increased Long-Term All-Cause Mortality Compared to Uncoated Devices.
    Dake MD; Ansel GM; Bosiers M; Holden A; Iida O; Jaff MR; Lottes AE; O'Leary EE; Saunders AT; Schermerhorn M; Yokoi H; Zeller T
    Cardiovasc Intervent Radiol; 2020 Jan; 43(1):8-19. PubMed ID: 31502026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
    Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
    Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infrainguinal disease treatment: to stent or not to stent.
    Dosluoglu H; Lall P
    J Cardiovasc Surg (Torino); 2011 Oct; 52(5):701-16. PubMed ID: 21894138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of drug-coated balloons in in-stent restenosis.
    Andrassy M; Celik S; Andrassy J; Lichtenberg MK; Brodmann M
    J Cardiovasc Surg (Torino); 2017 Aug; 58(4):501-507. PubMed ID: 28358184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Zilver® PTX® Single Arm Study: 12-month results from the TASC C/D lesion subgroup.
    Bosiers M; Peeters P; Tessarek J; Deloose K; Strickler S;
    J Cardiovasc Surg (Torino); 2013 Feb; 54(1):115-22. PubMed ID: 23296421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.
    Palmerini T; Biondi-Zoccai G; Della Riva D; Mariani A; Sabaté M; Smits PC; Kaiser C; D'Ascenzo F; Frati G; Mancone M; Genereux P; Stone GW
    J Am Coll Cardiol; 2014 Feb; 63(4):299-307. PubMed ID: 24211507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Commentary: infrapopliteal angioplasty with drug-eluting stents: from heart to toe.
    Siablis D; Katsanos K; Karnabatidis D
    J Endovasc Ther; 2010 Aug; 17(4):488-91. PubMed ID: 20681764
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.